查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1791410

全球危险药物分配系统市场报告：趋势、预测和竞争分析（至 2031 年）

Hazardous Drug Compounding System Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球危险药物分配系统市场前景光明，医院药局、门诊/社区药局以及研发实验室都蕴藏着巨大的机会。预计2025年至2031年期间，全球危险药物分配系统市场规模的复合年增长率将达到20.2%。推动该市场发展的关键因素包括安全法规的加强、危险药物使用量的增加以及对医护人员安全的重视。

  • Lucintel 预测，由于对无污染诊断剂的需求不断增长，以确保 PCR 测试的准确性和可靠性，无菌混合系统将在预测期内继续成为一个重要的领域。
  • 根据应用，由于对稳定、即用型试剂的需求不断增长，以减少医院实验室的设置时间，预计医院药房将继续成为最大的细分市场。
  • 按地区划分，预计北美在预测期内将经历最高的成长。

危险药品调配系统市场的新趋势

危险药物配製系统市场正在透过与提高安全性、效率和法规遵循相关的几个新兴趋势不断发展。

  • 危险药物配製自动化：危险药物配製市场最突出的趋势之一是自动化。诸如机器人配製系统和封闭式药物转移装置等自动化系统因其能够最大限度地减少人为错误和危险药物暴露而日益普及。此类技术提​​高了配製过程的准确性、一致性和安全性，尤其是在肿瘤诊所等高风险环境中，同时也减少了医护人员接触危险化学品的风险。
  • 封闭式药物转运装置 (CSTD) 需求日益增长：CSTD 是防止药物污染和暴露的固有工具，其需求日益增长。 CSTD 旨在防止危险药物在运输过程中释放到环境中。随着 FDA 和 OSHA 等监管机构对其使用的日益重视，CSTD 的使用预计将持续成长。 CSTD 特别旨在降低化疗药物和其他危险药物的暴露风险，进而保障医护人员和病患的安全。
  • 配药技术的改进：配药技术系统的进步使配药系统在配药方面更加精确高效，从而提高了危险药物使用的准确性和安全性。技术创新包括透过改进密封系统来提高剂量准确性，这是防止交叉污染和准确给药的关键。技术进步不断促使医疗保健机构更新其配药系统，采用更新的模型，以维持安全和法规的高标准。
  • 监管变化与合规性：世界各国政府和监管机构正在加强监管，并实施更严格的危险药物配製标准。製药公司和医疗机构正在投资符合这些新标准的设备。这一趋势推动了市场对更安全、合规的配製系统的需求。对监管合规性的日益重视，使得危险药物的处理更加安全，旨在保护医护人员和患者免受危险物质的侵害。
  • 工人安全：工人安全仍然是危险药物配製过程中最重要的部分。人们日益关注危险药物对医护人员和劳工的健康危害，促使人们更加重视开发保护工人接触的系统。这些系统包括隔离器、密闭装置和个人防护设备，以最大限度地减少与这些药物的直接接触。对工人安全的日益关注预计将成为先进配製系统需求的强劲驱动力。
  • 全球危险药品配製系统市场趋势：封闭式药物转运装置、技术进步、法规合规性、工人安全和自动化等趋势正在改变全球危险药品配製系统市场。随着这些趋势的不断发展，市场预计将随着药物配製过程中对安全性、效率和工艺合规性日益增长的需求而不断发展。

危险药物分配系统市场的最新发展

影响危险药物配製系统市场的关键发展包括安全性、技术和法规遵循的改善。

  • 自动配药系统：自动配药系统正在被广泛应用，以提高药物製备的准确性和安全性。这些系统可以最大限度地减少人为错误，提高效率，并能够安全地处理危险药物。医疗保健领域对自动化的需求日益增长，这加速了这些系统的普及，尤其是在肿瘤治疗中心等高风险环境中。这些系统不仅优化了流程，还帮助医疗机构遵守严格的安全标准。
  • 封闭式药物转运装置：封闭式药物转运装置旨在防止危险药物在运输过程中洩漏，避免污染和暴露风险，并确保更有效率的药物配製作业。随着全球监管机构不断强调药物配製安全性，医疗机构也要求为其服务购买封闭式系统。在这些机构中，处理危险药物和化疗治疗服务区正逐渐成为常态。
  • 提升安全性的监管措施：各国政府和监管机构正在加强危险药物配製的安全措施。 FDA 和 OSHA 指南的修订版等新法规正在迫使医疗机构实施更安全的业务，并投资先进的配製系统。这些法规降低了医护人员接触危险药物的风险，并确保药物配製的准确性和安全性。
  • 改良的密闭和隔离技术：密闭和隔离技术的改进使危险药物的配製更加安全。包括隔离器和生物安全柜在内的新型密闭系统正在开发中，以防止接触危险药物。这些技术透过创造安全的药物配製环境，提高了医护人员的防护。随着这些技术的进步，预计将被世界各地的医院和药房越来越多地采用。
  • 重视训练和教育：随着人们对危险药物安全问题的担忧日益加深，对配发这些药物的医护人员进行培训和教育也已成为关键问题。相关培训计画已陆续推出，旨在确保这些医护人员充分了解相关风险并了解如何处理危险药物。此外，市场上也涌现一些关于危险药物的教育倡议，旨在提升医护人员的知识和技能。

自动配药系统、CSTD、监管措施、密闭技术进步以及对培训的日益重视等发展，都使危险药品配药系统市场变得更加安全、高效和合规。基础设施的持续发展将显着改善危险药品的处理，并确保医护人员的安全。

目录

第一章执行摘要

第二章 市场概述

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 宏观经济趋势与预测
  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球危险药物分配系统市场（按类型）

  • 概述
  • 按类型分析吸引力
  • 无菌复合系统：趋势与预测（2019-2031）
  • 非无菌复合系统：趋势与预测（2019-2031）

5. 全球危险药物分配系统市场（依应用）

  • 概述
  • 按用途分析吸引力
  • 医院药局：趋势与预测（2019-2031）
  • 门诊/社区药局：趋势与预测（2019-2031）
  • 研发实验室：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第六章区域分析

  • 概述
  • 全球危险药品分配系统市场（按地区）

7.北美危险药物配製系统市场

  • 概述
  • 北美危险药品分配系统市场（按类型）
  • 北美危险药物复合系统市场（按应用）
  • 美国危险药物配製系统市场
  • 墨西哥危险药品分配系统市场
  • 加拿大危险药物配製系统市场

8.欧洲危险药物分配系统市场

  • 概述
  • 欧洲危险药品分配系统市场（按类型）
  • 欧洲危险药物分配系统市场（按应用）
  • 德国危险药品分配系统市场
  • 法国危险药品分配系统市场
  • 西班牙危险药品分配系统市场
  • 义大利危险药品分配系统市场
  • 英国危险药物分配系统市场

9. 亚太地区危险药物分配系统市场

  • 概述
  • 亚太地区危险药品分配系统市场（按类型）
  • 亚太地区危险药品分配系统市场（依应用）
  • 日本危险药品配製系统市场
  • 印度危险药品分配系统市场
  • 中国危险药品分配系统市场
  • 韩国危险药品配製系统市场
  • 印尼危险药品分配系统市场

10. 世界其他地区危险药物分配系统市场

  • 概述
  • 世界其他地区危险药物分配系统市场（按类型）
  • 世界其他地区危险药物分配系统市场（按应用）
  • 中东危险药品分配系统市场
  • 南美洲危险药品分配系统市场
  • 非洲危险药物分配系统市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市场占有率分析

第十二章机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球危险药物配製系统市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 合併、收购、协议、合作和合资企业

第十三章：价值链主要企业概况

  • 竞争分析
  • BD Medical
  • Equashield
  • ICU Medical
  • Simplivia
  • B. Braun
  • Baxter
  • Comecer
  • Grifols
  • ARxiUM
  • Newlcon

第十四章 附录

  • 图表一览
  • 表格一览
  • 调查方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global hazardous drug compounding system market looks promising with opportunities in the hospital pharmacies, outpatient/community pharmacies, and research and development laboratories markets. The global hazardous drug compounding system market is expected to grow with a CAGR of 20.2% from 2025 to 2031. The major drivers for this market are the increasing safety regulations, the rising use of hazardous drugs, and the focus on improving healthcare worker safety.

  • Lucintel forecasts that, within the type category, sterile compounding systems will remain the larger segment over the forecast period due to rising demand for contamination-free diagnostic reagents to ensure accuracy and reliability in PCR testing.
  • Within the application category, hospital pharmacies will remain the largest segment due to increasing demand for stable, ready-to-use reagents that reduce preparation time in hospital laboratories.
  • In terms of region, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Hazardous Drug Compounding System Market

The hazardous drug compounding system market is evolving through several emerging trends that are concerned with the betterment of safety, efficiency, and regulatory compliance.

  • Hazardous Drug Compounding Automation: One of the most prominent trends in the hazardous drug compounding market is automation. Automated systems, such as robotic compounding systems and closed-system drug transfer devices, are being adopted increasingly due to their potential to minimize human error and exposure to dangerous drugs. Such technologies improve the accuracy, consistency, and safety of the compounding process so that healthcare workers are not exposed to hazardous chemicals, especially in high-risk environments like oncology clinics.
  • Emerging Demand for Closed System Transfer Devices (CSTDs): There is a rising demand for CSTDs that act as an inherent tool in preventing the contamination and exposure of drugs. CSTDs are a system designed to prevent hazardous drugs from escaping into the environment while transferring, and their usage will continue to grow as regulatory agencies such as the FDA and OSHA place emphasis on using them. Particularly, CSTDs are aimed at reducing risk in exposure to chemotherapy agents and other hazardous drugs, hence safety for both the healthcare workers and the patients.
  • Improved Compounding Technology: Advances in technological systems in compounding are ensuring that more exact and efficient preparations of drugs by the compounding system enhance accuracy and safety in the use of hazardous drugs. Innovations in technology consist of better dosing accuracy with improved containment systems which are a gateway to the absence of cross-contamination and correct doses of drugs. Technological advances keep pushing healthcare institutions to update newer models of compounding systems for sustained high standards on safety and regulations.
  • Regulatory Changes and Standards Compliance: Governments and regulatory agencies around the world are tightening regulations and enforcing stricter standards for hazardous drug compounding. Pharmaceutical companies and healthcare facilities are investing in equipment that meets these new standards. This trend is driving the market for safer, more compliant compounding systems. The increased focus on regulatory compliance ensures that hazardous drugs are handled more safely, with the goal of protecting both healthcare workers and patients from exposure to dangerous substances.
  • Worker Safety: Worker safety continues to be the most essential aspect of hazardous drug compounding. Given increased concerns regarding the health hazards of hazardous drugs to healthcare personnel and workers, there is more effort put into developing systems that safeguard worker exposure. These systems are defined as isolators, containment devices, and personal protective equipment that minimize direct contact with these drugs. This growth in focus on worker safety will be a strong factor in the demand for advanced systems of compounding.
  • Global Hazardous Drug Compounding System Market Trends: Closed-system transfer devices, advancements in technology, regulatory compliance, worker safety, and automation trends are transforming the global hazardous drug compounding system market. As these trends continue evolving, the market is expected to advance as well as develop, based on an increase in demand for safety, efficiency, and compliance with processes in drug compounding.

Recent Developments in the Hazardous Drug Compounding System Market

Some of the key developments influencing the hazardous drug compounding system market are safety, technology, and regulatory compliance improvements.

  • Automated Compounding Systems: Automated compounding systems are being put in place to develop greater accuracy and safety for drug preparation. These systems minimize the human error aspects, efficiency, and safely working with hazardous drugs. The expanding demand for automation in healthcare is accelerating the uptake of these systems, especially in high-risk settings like oncology treatment centers. These systems are facilitating healthcare providers' observance of strict standards on safety while optimizing the process.
  • Closed-system Drug Transfer Devices: Closed-system drug transfer devices, designed to avoid releasing hazardous drugs while the transfer is undergoing, ensure drug compounding operations are more effective in avoiding the risk of contamination and exposure. Since all regulatory agencies all over the globe are insisting that safety in compounding is promoted, healthcare institutions are demanding the purchase of closed systems for their services. In these facilities, it's becoming a standard with hazardous drugs' handling and a chemotherapy treatment service area.
  • Regulatory Initiatives to Improve Safety Measures: Governments and regulatory agencies are tightening safety measures for hazardous drug compounding. New regulations, such as the revised guidelines of the FDA and OSHA, are compelling healthcare facilities to take safer practices and invest in advanced compounding systems. These regulations will reduce the risk of hazardous drug exposure for healthcare workers and ensure that drugs are compounded accurately and safely.
  • Improvements in Containment and Isolation Technology: Improved containment and isolation technology have enhanced the safety of hazardous drug compounding. New containment systems, including isolators and biological safety cabinets, are being developed to prevent exposure to hazardous drugs. These technologies provide improved protection for healthcare workers by creating secure environments for drug compounding. As these technologies advance, they are expected to increase their adoption in hospitals and pharmacies around the world.
  • Focus on Training and Education: The number of safety concerns about hazardous drugs is on the rise, and so is the training and education of healthcare workers in compounding these drugs. Training programs are being designed to ensure that these workers are well equipped with the dangers and handling of these hazardous drugs. Moreover, educational initiatives related to hazardous drugs have appeared on the market to enhance the knowledge and skills of healthcare professionals.

All these advancements about developing automated compounding systems, CSTDs, regulatory initiatives, advancement in containment technology, and high focus on training are making the hazardous drug compounding system market safer, more efficient, and compliant. As these development infrastructures continue to pop up, they would significantly improve the handling of hazardous drugs and safeguard the healthcare worker.

Strategic Growth Opportunities in the Hazardous Drug Compounding System Market

The global market for hazardous drug compounding systems comprises several growth prospects across key applications that include oncology drug compounding.

  • Oncology Drug Compounding: The greatest growth opportunity in hazardous drug compounding systems is represented by oncology drug compounding. This fact is supported by the increasing incidence of cancer, coupled with the growing demand for chemotherapy drugs and treatment. Automated systems and CSTDs are particularly advantageous in oncology environments to prevent both contamination and exposure of toxic chemotherapy agents.
  • Pharmacy Compounding Services: Pharmacy compounding services are the other area of growth, as healthcare providers seek customized medicines for patients. As regulations for compounding hazardous drugs are tightened, pharmacies opt for advanced systems that can meet the safety standards in preparation while assuring the exact drug preparation. The growth of personalized medicine and patient-specific formulations of drugs is going to keep up the demand for hazardous drug compounding systems in the pharmacies.
  • Hospital and Clinic Adoption: Hazardous drug compounding systems are very important to hospitals and clinics that offer chemotherapy treatment. There is a growing interest in worker safety and regulatory compliance, which will cause healthcare facilities to adopt more advanced compounding technologies. These systems ensure accurate and safe drug preparation and are, therefore, essential in settings where patient safety and staff protection are the most important concerns.
  • Veterinary Applications: Hazardous drug compounding systems have growing applications in veterinary medicine. As the use of hazardous drugs in veterinary oncology and other treatments increases, so does the need for systems that can compound and prepare them safely. Veterinary clinics and hospitals are incorporating automated compounding systems into their facilities to make the preparation of drugs safer and more efficient. Growth in this sector is becoming a result of adapting to such changes.
  • Environmental and Safety Monitoring: The hazardous drug compounding market is witnessing an emerging growth opportunity in the form of environmental and safety monitoring. Importantly, monitoring systems assure the safe handling of hazardous drugs and track the resultant exposure levels; these are impacting significantly. Since healthcare facilities must comply with regulatory standards and maintain a safe environment for workers, there is much demand for comprehensive safety and environmental monitoring solutions.

These growth opportunities are based on oncology drug compounding, pharmacy services, hospital and clinic adoption, veterinary applications, and environmental monitoring, and will shape the future of the hazardous drug compounding system market. Demand for safer, more efficient systems will continue to drive market expansion based on these applications.

Hazardous Drug Compounding System Market Driver and Challenges

There are several drivers and challenges that are influencing the hazardous drug compounding system market, which includes technological, regulatory, and economic factors.

The factors responsible for driving the hazardous drug compounding system market include:

1. Advancements in Compounding Technology: Technological advancement is one of the major factors propelling the hazardous drug compounding system market. New automated systems, improved drug transfer devices, and containment technologies enhance the safety and efficiency of the drug compounding process. The innovation makes it easy for healthcare facilities to comply with the regulatory requirements and ensure the safety of healthcare workers and patients.

2. Focus on Worker Safety: With increased awareness regarding the risks of harmful drugs, there is a great need for safer compounding systems. There is an increasing emphasis on healthcare worker safety, which drives the adoption of technologies designed to minimize harmful exposures to hazardous substances. It is these increases in worker safety that are moving the markets toward greater advances in more protective compounding solutions.

3. Toughest Regulatory Standards: Stricter regulations by the FDA and OSHA for hazardous drug compounding are stimulating the growth in the hazardous drug compounding system market. In this regard, stringent regulations demand healthcare facilities to adopt safer methods of drug compounding, resulting in the rising demand for sophisticated systems that will meet these standards.

Challenges in the hazardous drug compounding system market are:

1. High Costs of Advanced Systems: The cost of advanced hazardous drug compounding systems is a significant challenge, especially for smaller healthcare facilities. These systems often require significant investments in equipment and training. High costs may deter the widespread adoption of these systems, especially in developing regions.

2. Regulatory Compliance Issues: While regulatory guidelines are pushing innovation, navigating the complex regulatory landscape for hazardous drug compounding systems is challenging. Constant updates to equipment and processes are necessary to keep pace with evolving safety standards, which can be time-consuming and costly for healthcare facilities.

3. Low awareness in emerging markets: The lack of awareness of drug compounding safety in hazardous situations in emerging markets is a key challenge to this market's growth. Most developing regions' hospitals and healthcare settings do not possess the necessary materials and knowledge base to implement leading-edge compounding systems. An awareness campaign concerning the need to compound drugs is essential for business expansion in those regions.

The hazardous drug compounding system market is driven by technological advancements, a focus on worker safety, and regulatory guidelines. Challenges such as high costs, regulatory compliance, and limited awareness in emerging markets are expected to impact the sustainability of market growth.

List of Hazardous Drug Compounding System Companies

  • Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, hazardous drug compounding system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hazardous drug compounding system companies profiled in this report include:
  • BD Medical
  • Equashield
  • ICU Medical
  • Simplivia
  • B. Braun
  • Baxter
  • Comecer
  • Grifols
  • ARxiUM
  • Newlcon

Hazardous Drug Compounding System Market by Segment

The study includes a forecast for the global hazardous drug compounding system market by type, application, and region.

Hazardous Drug Compounding System Market by Type [Value from 2019 to 2031]:

  • Sterile Compounding Systems
  • Non-Sterile Compounding Systems

Hazardous Drug Compounding System Market by Application [Value from 2019 to 2031]:

  • Hospital Pharmacies
  • Outpatient/Community Pharmacies
  • Research and Development Laboratories
  • Others

Hazardous Drug Compounding System Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Hazardous Drug Compounding System Market

The global hazardous drug compounding system market has experienced rapid developments in the past few years, which are attributed to growing regulations and a safety focus in pharmaceutical compounding. Hazardous drug compounding is crucial in the preparation of drugs that are considered dangerous, such as chemotherapy agents. As awareness regarding the safe handling and preparation of these drugs increases, changes in regulations, technological advancements, and market demands are seen in countries such as the United States, China, Germany, India, and Japan. The market is responding with new innovations in compounding systems designed to protect healthcare workers and improve the overall efficiency of drug preparation.

  • United States: This market, especially in the United States, is growing at an incredible pace due to stringent regulations by the FDA and OSHA. The push by the FDA for stiffer standards on compounding hazardous drugs, as enshrined in the Drug Quality and Security Act, among others, will influence the market. Investments in safer and more efficient compounding technologies are being made by pharmaceutical companies to adhere to these regulations. In addition, the need for automated compounding systems is growing, with healthcare facilities looking for ways to reduce human error and exposure to hazardous drugs, thus providing a safer workplace for staff.
  • China: The Chinese hazardous drug compounding system market is rapidly growing, with the government strengthening its regulations on the safe handling of hazardous drugs. Growth in the Chinese pharmaceutical industry has also been stimulated through increasing demand for advanced drug compounding systems in oncology and chemotherapy treatments. Though the country has some difficulties with training workers and raising the public's awareness regarding safety standards, automation of compounding systems is the emerging trend. This change to automation will ensure that the drugs are prepared with greater efficiency and accuracy while at the same time reducing the dangers of handling hazardous drugs.
  • Germany: Germany is moving its hazardous drug compounding system market forward with emphasis on safety for the workers and adherence to the regulatory requirements. The European Union's efforts to increase the strictness of guidelines on the handling of drugs have led Germany to use more advanced compounding technologies to adhere to the new standards of safety. The country has been embracing the use of closed-system drug transfer devices (CSTDs) and automated compounding devices in reducing the risks of drug contamination and exposure. The German market is expected to grow further because of the need for safety in drug compounding, especially in hospitals and oncology clinics.
  • India: The hazardous drug compounding system market in India is increasing because of awareness about the risk associated with handling hazardous drugs. The pharmaceutical industry is expanding rapidly, and the number of cancer treatments is increasing. It is more crucial now than ever to have effective drug compounding systems. However, India lags behind in awareness and training in the right safety protocols. Still, there is a trend towards automation, which is reducing safety concerns and improving efficiency in drug compounding. According to the improvement and spreading awareness, India's hazardous drug compounding systems shall continue to market, which is gradually increasing.
  • Japan: Japan's hazardous drug compounding system evolves with a clear focus on safety with its precision. Such a country seeks advanced compounding systems due to the increasing interest in oncological treatments and striving healthcare worker protection standards. This means that the country's healthcare sector has increasingly begun to adopt automated systems and technology for safer and efficient compounding. Additionally, there is an increase in the proportion of elderly citizens in the population that further leads to more patients seeking chemotherapy treatment. Japan is likely to continue on a straight growth path in the hazardous drug compounding system market as it continues improving the safety standards surrounding the handling of hazardous drugs.

Features of the Global Hazardous Drug Compounding System Market

  • Market Size Estimates: Hazardous drug compounding system market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Hazardous drug compounding system market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Hazardous drug compounding system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hazardous drug compounding system market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hazardous drug compounding system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the hazardous drug compounding system market by type (sterile compounding systems and non-sterile compounding systems), application (hospital pharmacies, outpatient/community pharmacies, research and development laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Hazardous Drug Compounding System Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Sterile Compounding Systems: Trends and Forecast (2019-2031)
  • 4.4 Non-Sterile Compounding Systems: Trends and Forecast (2019-2031)

5. Global Hazardous Drug Compounding System Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital Pharmacies: Trends and Forecast (2019-2031)
  • 5.4 Outpatient/Community Pharmacies: Trends and Forecast (2019-2031)
  • 5.5 Research and Development Laboratories: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Hazardous Drug Compounding System Market by Region

7. North American Hazardous Drug Compounding System Market

  • 7.1 Overview
  • 7.2 North American Hazardous Drug Compounding System Market by Type
  • 7.3 North American Hazardous Drug Compounding System Market by Application
  • 7.4 United States Hazardous Drug Compounding System Market
  • 7.5 Mexican Hazardous Drug Compounding System Market
  • 7.6 Canadian Hazardous Drug Compounding System Market

8. European Hazardous Drug Compounding System Market

  • 8.1 Overview
  • 8.2 European Hazardous Drug Compounding System Market by Type
  • 8.3 European Hazardous Drug Compounding System Market by Application
  • 8.4 German Hazardous Drug Compounding System Market
  • 8.5 French Hazardous Drug Compounding System Market
  • 8.6 Spanish Hazardous Drug Compounding System Market
  • 8.7 Italian Hazardous Drug Compounding System Market
  • 8.8 United Kingdom Hazardous Drug Compounding System Market

9. APAC Hazardous Drug Compounding System Market

  • 9.1 Overview
  • 9.2 APAC Hazardous Drug Compounding System Market by Type
  • 9.3 APAC Hazardous Drug Compounding System Market by Application
  • 9.4 Japanese Hazardous Drug Compounding System Market
  • 9.5 Indian Hazardous Drug Compounding System Market
  • 9.6 Chinese Hazardous Drug Compounding System Market
  • 9.7 South Korean Hazardous Drug Compounding System Market
  • 9.8 Indonesian Hazardous Drug Compounding System Market

10. ROW Hazardous Drug Compounding System Market

  • 10.1 Overview
  • 10.2 ROW Hazardous Drug Compounding System Market by Type
  • 10.3 ROW Hazardous Drug Compounding System Market by Application
  • 10.4 Middle Eastern Hazardous Drug Compounding System Market
  • 10.5 South American Hazardous Drug Compounding System Market
  • 10.6 African Hazardous Drug Compounding System Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Hazardous Drug Compounding System Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 BD Medical
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Equashield
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 ICU Medical
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Simplivia
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 B. Braun
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Baxter
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Comecer
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Grifols
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 ARxiUM
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Newlcon
    • Company Overview
    • Hazardous Drug Compounding System Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Hazardous Drug Compounding System Market
  • Figure 2.1: Usage of Hazardous Drug Compounding System Market
  • Figure 2.2: Classification of the Global Hazardous Drug Compounding System Market
  • Figure 2.3: Supply Chain of the Global Hazardous Drug Compounding System Market
  • Figure 2.4: Driver and Challenges of the Hazardous Drug Compounding System Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Hazardous Drug Compounding System Market ($B) by Type
  • Figure 4.3: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.1: Global Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Hazardous Drug Compounding System Market ($B) by Application
  • Figure 5.3: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Hazardous Drug Compounding System Market (2019-2031)
  • Figure 6.1: Trends of the Global Hazardous Drug Compounding System Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Hazardous Drug Compounding System Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Hazardous Drug Compounding System Market (2019-2031)
  • Figure 7.2: North American Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Hazardous Drug Compounding System Market (2019-2031)
  • Figure 8.2: European Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 8.5: European Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Hazardous Drug Compounding System Market (2019-2031)
  • Figure 9.2: APAC Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Hazardous Drug Compounding System Market (2019-2031)
  • Figure 10.2: ROW Hazardous Drug Compounding System Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Hazardous Drug Compounding System Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Hazardous Drug Compounding System Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Hazardous Drug Compounding System Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Hazardous Drug Compounding System Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Hazardous Drug Compounding System Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Hazardous Drug Compounding System Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Hazardous Drug Compounding System Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Hazardous Drug Compounding System Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Type
  • Figure 12.2: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Application
  • Figure 12.3: Growth Opportunities for the Global Hazardous Drug Compounding System Market by Region
  • Figure 12.4: Emerging Trends in the Global Hazardous Drug Compounding System Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Hazardous Drug Compounding System Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Hazardous Drug Compounding System Market by Region
  • Table 1.3: Global Hazardous Drug Compounding System Market Parameters and Attributes
  • Table 3.1: Trends of the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 3.2: Forecast for the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Hazardous Drug Compounding System Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.4: Trends of Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.5: Forecast for Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 4.6: Trends of Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 4.7: Forecast for Non-Sterile Compounding Systems in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Hazardous Drug Compounding System Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.4: Trends of Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.5: Forecast for Hospital Pharmacies in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.6: Trends of Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.7: Forecast for Outpatient/Community Pharmacies in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.8: Trends of Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.9: Forecast for Research and Development Laboratories in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Hazardous Drug Compounding System Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.1: Trends of the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.2: Forecast for the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Hazardous Drug Compounding System Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Hazardous Drug Compounding System Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Hazardous Drug Compounding System Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Hazardous Drug Compounding System Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.1: Trends of the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.2: Forecast for the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Hazardous Drug Compounding System Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Hazardous Drug Compounding System Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Hazardous Drug Compounding System Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.1: Trends of the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.2: Forecast for the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Hazardous Drug Compounding System Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Hazardous Drug Compounding System Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Hazardous Drug Compounding System Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.1: Trends of the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.2: Forecast for the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Hazardous Drug Compounding System Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Hazardous Drug Compounding System Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Hazardous Drug Compounding System Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Hazardous Drug Compounding System Market (2019-2031)
  • Table 11.1: Product Mapping of Hazardous Drug Compounding System Suppliers Based on Segments
  • Table 11.2: Operational Integration of Hazardous Drug Compounding System Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Hazardous Drug Compounding System Revenue
  • Table 12.1: New Product Launches by Major Hazardous Drug Compounding System Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Hazardous Drug Compounding System Market